Learn More
Medchemexpress LLC PKI-166 10mg | 187724-61-4 | 330.38 | C20H18N4O | 10 MG

Supplier: Medchemexpress LLC HY11715510MG
PKI-166 is a potent, selective, and orally bioavailable epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with a reported IC50 of 0.7 nM. It is provided for research use only and has molecular formula C20H18N4O and high purity by HPLC.
- Potent EGFR kinase inhibition (IC50 ≈ 0.7 nM).
- High chemical purity (≥98% by HPLC).
- Suitable for in vitro and in vivo research applications.
- Orally bioavailable in preclinical studies.
- Well-characterized molecular properties for experimental reproducibility.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.